EA
ASPX

Emerald Advisers’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Emerald Advisers’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-109,230
Closed -$2.8M – 378
2014
Q3 		$2.8M Buy
+109,230
New +$2.32M 0.17% 171
2014
Q2 		– Sell
-41,390
Closed -$1.27M – 453
2014
Q1 		$1.27M Buy
+41,390
New +$1.11M 0.07% 235

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Emerald Advisers's ASPX Position: Q4 2014 in Review

Emerald Advisers sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q4 2014, closing a stake of 109,230 shares — an estimated $2.8M sold.

Emerald Advisers first reported a position in ASPX in Q1 2014 and held it in 2 quarters. The position peaked at $2.8M in Q3 2014. 89 funds tracked by Wall St. Rank hold ASPX as of Q4 2014.

  • Emerald Advisers reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Emerald Advisers sold 109,230 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $2.8M.
  • Emerald Advisers first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Emerald Advisers's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.8M in Q3 2014.
  • 89 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Emerald Advisers's 13F filing for Q4 2014, filed 30 Jan 2015.